AgaP_AGAP002164 cDNA ORF clone, Anopheles gambiae str. PEST

  • Gene

  • Clones

  • gRNAs

The following AgaP_AGAP002164 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the AgaP_AGAP002164 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID Accession No. Definition **Vector *Turnaround time Price (USD) Select
OAh00480 XM_308027.2
Latest version!
Anopheles gambiae str. PEST AGAP002164-RA (AgaP_AGAP002164), partial mRNA. pcDNA3.1-C-(k)DYK or customized vector 7-9 $104.30
$149.00

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.

  • Reference Sequences (Refseq)
    CloneID OAh00480
    Clone ID Related Accession (Same CDS sequence) XM_308027.2
    Accession Version XM_308027.2 Latest version! Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 261bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2018-04-25
    Organism Anopheles gambiae str. PEST
    Product AGAP002164-PA
    Comment Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. This record is derived from an annotated genomic sequence (NT_078266). On Dec 7, 2006 this sequence version replaced XM_308027.1. COMPLETENESS: incomplete on both ends.

    1
    61
    121
    181
    241
    ATGAGCCTAA GCTATCTGTC GCTCATACGT GGCTGCTCTC CTAAGAAACT GTTTTCATGC 
    CAGCTGTGTG GCAAAGTGCT GTGCTCGAAA GCGTCGCTGA AGCGGCACAT CGCCGACAAA
    CATGCGGAAA GGCAGGAAGA GTATCGGTGC ATCATATGCG AGCGCGTCTA CTGTTCGCGC
    AACTCCTTGA TGACGCATAT CTACACCTAC CACAAGTCCC GGCCCGGCGA GCTGGACATG
    AAGGATGTAA AGTTCTTCTA G

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq XP_308027.2
    CDS1..261
    Translation

    Target ORF information:

    RefSeq Version XM_308027.2
    Organism Anopheles gambiae str. PEST
    Definition Anopheles gambiae str. PEST AGAP002164-RA (AgaP_AGAP002164), partial mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    XM_308027.2

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    ATGAGCCTAA GCTATCTGTC GCTCATACGT GGCTGCTCTC CTAAGAAACT GTTTTCATGC 
    CAGCTGTGTG GCAAAGTGCT GTGCTCGAAA GCGTCGCTGA AGCGGCACAT CGCCGACAAA
    CATGCGGAAA GGCAGGAAGA GTATCGGTGC ATCATATGCG AGCGCGTCTA CTGTTCGCGC
    AACTCCTTGA TGACGCATAT CTACACCTAC CACAAGTCCC GGCCCGGCGA GCTGGACATG
    AAGGATGTAA AGTTCTTCTA G

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

  • PubMed

    The Anopheles gambiae genome: an update.
    Trends in parasitology20(2)49-52(2004 Feb)
    Mongin E,Louis C,Holt RA,Birney E,Collins FH


    The genome sequence of the malaria mosquito Anopheles gambiae.
    Science (New York, N.Y.)298(5591)129-49(2002 Oct)
    Holt RA,Subramanian GM,Halpern A,Sutton GG,Charlab R,Nusskern DR,Wincker P,Clark AG,Ribeiro JM,Wides R,Salzberg SL,Loftus B,Yandell M,Majoros WH,Rusch DB,Lai Z,Kraft CL,Abril JF,Anthouard V,Arensburger P,Atkinson PW,Baden H,de Berardinis V,Baldwin D,Benes V,Biedler J,Blass C,Bolanos R,Boscus D,Barnstead M,Cai S,Center A,Chaturverdi K,Christophides GK,Chrystal MA,Clamp M,Cravchik A,Curwen V,Dana A,Delcher A,Dew I,Evans CA,Flanigan M,Grundschober-Freimoser A,Friedli L,Gu Z,Guan P,Guigo R,Hillenmeyer ME,Hladun SL,Hogan JR,Hong YS,Hoover J,Jaillon O,Ke Z,Kodira C,Kokoza E,Koutsos A,Letunic I,Levitsky A,Liang Y,Lin JJ,Lobo NF,Lopez JR,Malek JA,McIntosh TC,Meister S,Miller J,Mobarry C,Mongin E,Murphy SD,O'Brochta DA,Pfannkoch C,Qi R,Regier MA,Remington K,Shao H,Sharakhova MV,Sitter CD,Shetty J,Smith TJ,Strong R,Sun J,Thomasova D,Ton LQ,Topalis P,Tu Z,Unger MF,Walenz B,Wang A,Wang J,Wang M,Wang X,Woodford KJ,Wortman JR,Wu M,Yao A,Zdobnov EM,Zhang H,Zhao Q,Zhao S,Zhu SC,Zhimulev I,Coluzzi M,della Torre A,Roth CW,Louis C,Kalush F,Mural RJ,Myers EW,Adams MD,Smith HO,Broder S,Gardner MJ,Fraser CM,Birney E,Bork P,Brey PT,Venter JC,Weissenbach J,Kafatos FC,Collins FH,Hoffman SL